Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue in Septic Shock
NCT04970602Unknown
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Jun 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of methylene blue in septic shock (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoint: Sequential Organ Failure Assessment Score at 72 hours. Status: unknown.
02
Drugs
methylene blue
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT04970602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04970602.